ICE scientific team has much experience on PROTAC related assays in past few years, and now is expanding capacity on novel target validation including E3 ligase and protein of interest, develop both biochemical and cellular assays, HiBiT knock-in cell lines, drug resistant cell lines, HTS protein degradation assays, MOA study, troubleshooting study etc.
ICE is now expanding Biologics screening platform, CGT service like oncolytic virus, AAV, exosome, CAR-NK related capability, also collaborate with technical company with expertise on Proteomics analysis, DEL library, small molecule library, AI-based in silico screening and so on. We will share more in the months to come.
We value your inquiries and are here to provide you with tailored solutions for your drug discovery and development needs. Whether you have questions, require more information, or are interested in discussing potential collaborations, our team of experts is just a message away.
Feel free to reach out to us.
Address: Bldg 16, Yd 18, Kechuang 13th St, Etown, Tongzhou Dist, Beijing, 100176, China
Email: marketing@ice-biosci.com
Tel：+86-10-67809840
